Algen Biotechnologies
YC W20San Francisco, US · Founded 2018 · 15 employees · 4 known investors
Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.
Also known as Inc.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCRISPRTherapeuticsDrug discoveryAIUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (W20)
Algen Biotechnologies was founded in 2018 by Chun-Hao Huang, Christine Du, and Jennifer Doudna.
CH
Chun-Hao HuanginCo-Founder & CEOChun-Hao Huang is co-founder and CEO of Algen Biotechnologies, which develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to identify functional gene networks and predict drug responses.
CD
Christine DuinCo-Founder & CBOChristine Du is co-founder and chief business officer of Algen Biotechnologies, which develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning.
JD
Jennifer Doudna
DJ
Dr. Jeff WhittenChief Scientific Officer
Investors · 4
Competitors · 2
by search overlap
Generate Biomedicines14 shared keywordsGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
BreezeBio10 shared keywordsBreezeBio develops a programmable platform called NanoGalaxy for targeted delivery of genetic medicines, aiming to move genetic payloads to specific cells and tissues. The company operates in the biotech and genetic therapeutics space.
Companies competing with Algen Biotechnologies for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Algen Biotechnologies do?
- Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.
- Who founded Algen Biotechnologies?
- Algen Biotechnologies was founded by Chun-Hao Huang, Christine Du, Jennifer Doudna in 2018.
- Who are Algen Biotechnologies's investors?
- Algen Biotechnologies's investors include Cota Capital, Draper Associates, Rebel Fund, Y Combinator.
- Where is Algen Biotechnologies headquartered?
- Algen Biotechnologies is headquartered in San Francisco, US.